Friday, May 25, 2012

Diabetes Drug Target Identified

Patrick Tso, PhD, professor in the UC Department of Pathology and Laboratory Medicine, has published research on the ability of apoA-IV to reduce blood sugar levels and enhance insulin secretion.
The results appear the week of May 21, 2012, in the online early edition of Proceedings of the National Academy of Sciences.
ApoA-IV is secreted by the small intestine in response to fat absorption. Previous studies have shown apoA-IV to be elevated in humans following gastric bypass -- coinciding with improvement in symptoms for diabetes.

Read more - Diabetes drug target identified
Post a Comment